James Kee, MD
Orthopaedic Surgery · Searcy, ARNPI 1902340318
Payments from drug & device makers
What this record shows
This record is dominated by grants: $20,000 of the $26,945 with a category attached, or 74.2%. Arthrex accounts for 74.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $23,189 and has fallen 99.2% since, to $177 in 2025.
Across 38 payments — averaging $709.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$20K
- Smith+Nephew$6K
- CGG Medical Inc$868
- Stryker$136
- Vericel Corporation$124
- Vertex$61
- plus $216 from 9 others
What the payments were for
- Grants$20,00074%
- Food & beverage$1,5456%
- Education$5,40020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $20,000 |
| Smith+Nephew | 8 | $5,541 |
| CGG Medical Inc | 8 | $868 |
| Stryker | 7 | $136 |
| Vericel Corporation | 1 | $124 |
| Vertex | 3 | $61 |
| Heron Therapeutics, Inc. | 1 | $51 |
| DJO, LLC | 2 | $49 |
| Polynovo North America LLC | 1 | $19 |
| Organogenesis Inc. | 1 | $19 |
| Midsouth Orthopedics Inc. | 1 | $19 |
| Solventum Corporation | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
| Orthalign Inc | 1 | $15 |
| Eisai Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MACI$124
How this compares
$26,945 in reported general payments places this provider in the 85th percentile of 168 orthopaedic surgery providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 32 | $250 |
| Meloxicam | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Searcy
- Benjamin StronachLittle Rock$2.5M
- Charles BarnesLittle Rock$2.1M
- Kenneth MartinLittle Rock$322K
- Wesley CoxFayetteville$309K
- William HefleyNorth Little Rock$306K
- David BumpassLittle Rock$175K
- Lawrence O'MalleyLittle Rock$151K
- Jason BrandtJonesboro$104K
- Jason SmithLittle Rock$102K
- Richard McCarthyLittle Rock$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.